
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses continuing education opportunities for pharmacists to get trained on the proper use and administration of psychedelic drugs.
Pharmacy Times interviewed Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), on psychedelic medicine policy and current advancements in the field.
During the discussion, Ali addressed whether there are continuing education opportunities for pharmacists and other health care professionals to get trained on the proper use and administration of psychedelic drugs.




